Symptoms Predictive of Acute Myocardial Infarction in the Troponin Era: Analysis From the TRAPID-AMI Study.


Journal

Critical pathways in cardiology
ISSN: 1535-2811
Titre abrégé: Crit Pathw Cardiol
Pays: United States
ID NLM: 101165286

Informations de publication

Date de publication:
03 2019
Historique:
entrez: 13 2 2019
pubmed: 13 2 2019
medline: 18 6 2019
Statut: ppublish

Résumé

The TRAPID-AMI (High Sensitivity Cardiac Troponin T assay for rapid Rule-out of Acute Myocardial Infarction) study evaluated a rapid "rule-out" acute myocardial infarction (AMI). We evaluated what symptoms were associated with AMI as part of a substudy of TRAPID-AMI. There were 1282 patients evaluated from 12 centers in Europe, the United States of America, and Australia from 2011 to 2013. Multiple symptom variables were prospectively obtained and evaluated for association with the final diagnosis of AMI. Multivariate logistic regression analysis was done, and odds ratios (OR) were calculated. There were 213/1282 (17%) AMIs. Four independent predictors for the diagnosis of AMI were identified: radiation to right arm or shoulder [OR = 3.0; confidence interval (CI): 1.8-5.0], chest pressure (OR = 2.5; CI: 1.3-4.6), worsened by physical activity (OR = 1.7; CI: 1.2-2.5), and radiation to left arm or shoulder (OR = 1.7; CI: 1.1-2.4). In the entire group, 131 (10%) had radiation to right arm or shoulder, 897 (70%) had chest pressure, 385 (30%) worsened with physical activity, and 448 (35%) had radiation to left arm or shoulder. Duration of symptoms was not predictive of AMI. There were no symptoms predictive of non-AMI. Relationship between AMI size and symptoms was also studied. For 213 AMI patients, cardiac troponins I values were divided into 4 quartiles. Symptoms including pulling chest pain, supramammillary right location, and right arm/shoulder radiation were significantly more likely to occur in patients with larger AMIs. In a large multicenter trial, only 4 symptoms were associated with the diagnosis of AMI, and no symptoms that were associated with a non-AMI diagnosis.

Identifiants

pubmed: 30747759
doi: 10.1097/HPC.0000000000000163
pii: 00132577-201903000-00003
doi:

Substances chimiques

Biomarkers 0
Troponin 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-15

Subventions

Organisme : Department of Health
ID : PDF-2012-05-193
Pays : United Kingdom

Auteurs

James McCord (J)

From the Heart & Vascular Institute.

Lindsey Aurora (L)

Department of Internal Medicine, Henry Ford Hospital, Detroit, MI.

Bertil Lindahl (B)

Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

Evangelos Giannitsis (E)

Department of Internal Medicine III, Cardiology, Angiology, and Pulmonology, University Hospital Heidelberg, Heidelberg, Germany.

Carlos Calle-Muller (C)

Cardiology Division, Emory University School of Medicine, Atlanta, GA.

Richard Nowak (R)

Department of Emergency Medicine, Henry Ford Hospital, Detroit, MI.

Richard Body (R)

Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.

Michael Christ (M)

Department of Emergency and Critical Care Medicine, General Hospital, Paracelsus Medical University, Nuremberg, Germany.

Christopher R deFilippi (CR)

Department of Medicine, Inova Heart and Vascular Institute, Falls Church, VA.

Robert H Christenson (RH)

Department of Pathology, University of Maryland School of Medicine, Baltimore, MD.

Gordon Jacobsen (G)

Department of Public Health Sciences, Henry Ford Health System, Detroit, MI.

Aitor Alquezar (A)

Department of Emergency Medicine, Hospital de Sant Pau, Barcelona, Spain.

Mauro Panteghini (M)

Department of Biomedical and Clinical Sciences 'Luigi Sacco', University of Milan Medical School, Milano, Italy.

Dina Melki (D)

Department of Medicine, Karolinska Institutet, Huddinge, Sweden and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.

Mario Plebani (M)

Department of Laboratory Medicine, University Hospital of Padova, Padua, Italy.

Franck Verschuren (F)

Cliniques Universitaires St-Luc and Universite Catholique de Louvain, Brussels, Belgium.

John French (J)

Liverpool Hospital and University of New South Wales, Sydney, Australia.

Garnet Bendig (G)

Roche Diagnostics Germany, Penzberg, Germany.

Silvia Weiser (S)

Roche Diagnostics Germany, Penzberg, Germany.

Christian Mueller (C)

Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH